Primary and Metastatic Brain Tumours Assessed with the Brain and Torso [¹⁸F]FDG PET/CT Study Protocol-10 Years of Single-Institutional Experiences

• Main Authors: Agata Pietrzak (Author), Andrzej Marszałek (Author), Tomasz Piotrowski (Author), Adrianna Medak (Author), Katarzyna Pietrasz (Author), Julia Wojtowicz (Author), Hubert Szweda (Author), Krzysztof Matuszewski (Author), Witold Cholewiński (Author)
• Format: Book
• Published: MDPI AG, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

According to the international societies' recommendations, the 2-deoxy-2-[¹⁸F]fluoro-D-glucose positron emission tomography/computed tomography ([¹⁸F]FDG PET/CT) technique should not be used as the method of choice in brain tumour diagnosis. Therefore, the brain region can be omitted during standard [¹⁸F]FDG PET/CT scanning. We performed comprehensive literature research and analysed results from 14,222 brain and torso [¹⁸F]FDG PET/CT studies collected in 2010-2020. We found 131 clinically silent primary and metastatic brain tumours and 24 benign lesions. We concluded that the brain and torso [¹⁸F]FDG PET/CT study provides valuable data that may support therapeutic management by detecting clinically silent primary and metastatic brain tumours.

Item Description

10.3390/ph14080722
1424-8247